Medical devices and implements with liquid-impregnated surfaces

US11058803B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11058803-B2
Application numberUS-201715476708-A
CountryUS
Kind codeB2
Filing dateMar 31, 2017
Priority dateMay 24, 2012
Publication dateJul 13, 2021
Grant dateJul 13, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween. The impregnating liquid fills spaces between said solid features, the surface stably contains the impregnating liquid between the solid features, and the impregnating liquid is substantially held in place between the plurality of solid features regardless of orientation of the surface.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical device or medical implement with high lubricity to flesh or biological fluid and/or inhibited nucleation on its surface, the device or implement comprising: a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween, wherein said impregnating liquid fills spaces between said solid features, wherein said surface stably contains said impregnating liquid between said solid features, wherein at least a portion of the micro-scale and/or nano-scale solid features are non-submerged by the impregnating liquid when the surface is in contact with the flesh or the biological fluid, and wherein said impregnating liquid is substantially held in place between said plurality of solid features regardless of orientation of said surface, wherein 0<ϕ<0.3, where ϕ is a surface area fraction of the surface non-submerged by said impregnating liquid, and wherein said surface is a textured surface and said solid features are engineered protrusions or engineered particles of said textured surface. 2. The medical device or medical implement of claim 1 , wherein the solid features comprise particles having an average dimension in a range of 1 micron to 50 microns. 3. The medical device or medical implement of claim 1 , wherein the particles are arranged with average spacing of about 1 micron to about 30 microns between adjacent particles or clusters of particles. 4. The medical device or medical implement of claim 1 , wherein the particles are spray-deposited. 5. The medical device or medical implement of claim 1 , wherein the impregnating liquid comprises at least one member selected from the group consisting of ethyl oleate, an ester, a fatty acid, a fatty acid derivative, a vegetable oil, a terpene, phenyl isothiocyanate, bromobenzene, iodobenzene, o-bromotoluene, alpha-chloronaphthalene, alpha-bromonaphthalene, acetylene tetrabromide, 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl) imide, tribromohydrin, ethylene dibromide, carbon disulfide, bromoform, methylene iodide, stanolax, Squibb's liquid petrolatum, p-bromotoluene, monobromobenzene, perchloroethylene, carbon disulfide, phenyl mustard oil, monoiodobenzene, alpha-monochloro-naphthalene, acetylene tetrabromide, aniline, butyl alcohol, isoamyl alcohol, n-heptyl alcohol, cresol, oleic acid, linoleic acid, and amyl phthalate. 6. The medical device or medical implement of claim 1 , wherein the solid features comprise one or more members selected from the group consisting of wax, carnauba wax, beeswax, candelilla wax, zein, dextrin, cellulose ether, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethyl methyl cellulose, hydroxypropyl methyl cellulose, ethyl hydroxyethyl cellulose, insoluble fiber, purified wood cellulose, micro-crystalline cellulose, kaolinite, Japan wax, pulp, ferric oxide, iron oxide, sodium formate, sodium oleate, sodium palmitate, sodium sulfate, a metal, a polymer, a ceramic solid, a fluorinated solid, an intermetallic solid, and a composite solid PDMS, cyclic olefin polymer, polypropylene, PVC, PET, HDPE, polyimide, PMMA, glass, Perspex, Plexiglass, and Polymacon. 7. The medical device or medical implement of claim 1 , wherein the impregnating liquid comprises an additive to prevent or reduce evaporation of the impregnating liquid. 8. The medical device or medical implement of claim 1 , wherein the medical device or medical implement is a member selected from the group consisting of braces, dentures, a retainer, orthodonture, a bridge, an implant, a tooth/teeth mold, a prosthesis, an artificial organ, an artificial artery, a stent, a syringe, a lining, an IV tube, an IV bag, a colostomy bag, a surgical instrument, a bandage, and a blood pump. 9. The medical device or medical implement of claim 1 , wherein said medical device or medical implement is a blood pump or part thereof, wherein the surface is configured to provide reduction of shear forces to prevent damage to cells and/or other biological structures in blood or other biological fluids being pumped thereby or therethrough. 10. The medical device or medical implement of claim 1 , wherein said medical device or medical implement is a member selected from the group consisting of a pill, capsule, tablet, gel cap, and suppository. 11. The medical device or medical implement of claim 1 , wherein said medical device or medical implement is a member selected from the group consisting of a micropoipette, a small volume container of biological material, a human serum container, a pipette, a pipette tip, a microfluidic device, a dialysis machine, a tube, an endoscope, an intubation device, a syringe, a stent, a catheter, and a tracheotomy tube. 12. The medical device or medical implement of claim 1 , wherein said medical device or medical implement is a member selected from the group consisting of a glove, bandage, adhesive strip, drug release patch, and condom. 13. The medical device or medical implement of claim 1 , wherein said impregnating liquid comprises an antiseptic and/or an antibacterial. 14. The medical device or medical implement of claim 1 , wherein said impregnating liquid is curable and can be converted to a solid by curing. 15. The medical device or medical implement of claim 1 , wherein one or both of the following holds: (i) 0<ϕ<0.25, where ϕ is a surface area fraction of the surface non-submerged by said impregnating liquid, and wherein said surface is a textured surface and said solid features are engineered protrusions or engineered particles of said textured surface; and (ii) S ow(a) <0, where S ow(a) is spreading coefficient, defined as γ wa −γ wo −γ oa , where γ is the interfacial tension between the two phases designated by subscripts w, a, and o, where w is water, a is air, and a is the impregnating liquid. 16. The medical device or medical implement of claim 15 , wherein 0<ϕ≤0.25. 17. The medical device or medical implement of claim 15 , wherein 0.01<ϕ≤0.25. 18. The medical device or medical implement of claim 15 , wherein 0.01<ϕ≤0.10. 19. The medical device or medical implement of claim 15 , wherein S ow(a) <0. 20. The medical device or medical implement of claim 1 , wherein one or both of the following holds: (i) θ os(w),receding =0; and (ii) θ os(a),receding =0 and θ os(w),receding =0, where θ os(w),receding is receding contact angle of the impregnating liquid (subscript ‘o’) on the surface (subscript ‘s’) in the presence of water (subscript ‘w’), and where θ os(a),receding is receding contact angle of the impregnating liquid (subscript ‘o’) on the surface (subscript ‘s’) in the presence of air (subscript ‘a’).

Assignees

Inventors

Classifications

  • A61L27/28Primary

    Materials for coating prostheses · CPC title

  • Galenical forms not covered by A61K9/02 - A61K9/7023 · CPC title

  • characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084) · CPC title

  • Oils, fats, waxes or natural resins {(A61L15/225 takes precedence)} · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11058803B2 cover?
Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween. The impregnating liquid fills spaces …
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification A61L27/28. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).